በBoston፣ MA ለሜላኖማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሜላኖማ የሚደረጉ 26 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Tufts Medical Center, Boston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Local Institution - 0124, Boston
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital Cancer Institute, Boston
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
- Massachusetts General Hospital, Boston
Cryoablation+Ipilimumab+Nivolumab in Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital Cancer Center, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana-Farber Cancer Institute, Boston
Project: Every Child for Younger Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital Cancer Center, Boston
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Call for Information (Investigational Site 0026), Boston
Video Education With Result Dependent dIsclosure
ተሳታዮችን በመፈለግ ላይ
- Dana Farber Cancer Institute, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Dana Farber, Boston
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Massachusetts General Hospital, Boston
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center (BIDMC), Boston
- Dana Farber Cancer Institute, Boston
ACTengine® IMA203 Combined With mRNA-4203
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana Farber Cancer Institute, Boston
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana Farber Cancer Institute, Boston
በሌሎች ከተሞች ለሜላኖማ የሚደረጉ ጥናቶች
- Houston, TX59 ጥናቶች
- New York City, NY38 ጥናቶች
- Los Angeles, CA34 ጥናቶች
- Nashville, TN33 ጥናቶች
- Pittsburgh, PA31 ጥናቶች
- Philadelphia, PA23 ጥናቶች
- San Francisco, CA22 ጥናቶች
- Durham, NC21 ጥናቶች
- Atlanta, GA21 ጥናቶች
- St. Louis, MO21 ጥናቶች
- Salt Lake City, UT21 ጥናቶች
- Columbus, OH21 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።